Oncogene (2002) 21, 6557–6557. doi:10.1038/sj.onc.1205721
Correction to: Oncogene (2002) 21, 631–637. doi:10.1038/sj.onc.1205063
The authors wish to acknowledge support from the National Institutes of Health Lung Cancer SPORE program, grant P50CA70907.
Rights and permissions
About this article
Cite this article
Corey, D. Correction: Telomerase inhibition, oligonucleotides, and clinical trials. Oncogene 21, 6557 (2002). https://doi.org/10.1038/sj.onc.1205721
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205721